3Celli BR,MacNee W,AST/ERS Task Force.Standards for the diagnosis and treatment of patients wich COPD:a summary of AST/ERS position paper[J].Eur Respir J,2004,23:932-946.
4Patrick W,Webster K,Ludwig L,el al.Noninvasive positivepressure ventilation in acute respiratory distress without prior chronic respiratory failure[J].Am J Respir Crit Care Med,1996,153:1005-1011.
5Simonds AK.Long-term ventilation in obstructive ventilatory disorders[J].Respir Care Clin N Am,2002,8:533-544.
6Kallet RH,Diaz JV.The physiologic effects of noninvasive ventilation[J].Respir Care,2009,54:102-105.
8Chaouat A,Naeije R,Weitzenblum E.Pulmonary hypertension in COPD[J].Eur Respir J,2008,32:1371-1385.
二级参考文献25
1Naeije R. Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease. Proc Am Thorac Soc, 2005,2:20-22.
2Chaouat A, Naeije R. Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J, 2008,32 : 1371-1385.
3Hida W. Tun Y, Kikuchi Y, et al. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: recent advances in pathophysiology and management. Respirology, 2002.7:3-13.
4Barbera JA,Peinado VI,Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J, 2003, 21 :892-905.
5Vonbank K, Ziesche R, Higenbottam TW, et al. Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD. Thorax, 2003,58:289-293.
6Pison CM, Wolf JE, Levy PA, et al. Effects of captopril combined with oxygen therapy at rest and on exercise in patients with chronic bronchitis and pulmonary hypertension. Respiration, 1991,58 : 9-14.
7Kanazawa H. Hirata K, Yoshikawa J. Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD :a preliminary study. Thorax, 2003,58 : 629-631.
8Kiely DG, Cargill Rl, Wheeldon NM, et al. Haemodynamic and endocrine effects of type I angiotensin II receptor blockade in hypoxaemic cor pulmonale. Cardiovasc Res,1997, 33:201-208.
9Morrell NW, Higham MA, Phillips PG, et al. Pilot study of losartan for pulmonary hypertension in chronic obstructive pulmonary disease. Respir Res, 2005,6 : 88.
10Archer SL, Mike D,Crow J. et al. A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest, 1996,109:750-755.
6Chapman KR,Mannino DM,Soriano JB,et al.Epidemiology and costs of chronic obstruetive pulmonary disease[J].Eur Respir J,2006,27:188-207.
7Corner E,Garrod R.Does the addition of non-invasive ventilation during pulmonary rehabilitation in patients with chronic obstructive pulmonary disease augment patient outcome in exercise tolerance? A literature review[J].Physiother Res Int,2010,15(1):5-15.
8Thibout Y,Philit F,Freymond N,et al.Outcome in COPD patients treated with at-home,long-term,non-invasive ventilation[J].Rev Mal Respir,2006,23(5):438-444.
9Celli BR,Mac Nee W,Agusti A,et al.Standards for the diagnosis and treatment of patients with COPD:a summary of the ATC/FRC position paper[J].Eur Respir J,2004,23:932-946.
10Patrick W,Webster K,Ludwig L,el al.Noninvasive positive pressure ventilation in acute respiratory distress without prior chronic respiratory failure[J].Am J Respir Crit Care Med,1996,153:1005-1011.
